These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


688 related items for PubMed ID: 18314357

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C, Lin D, Wang J, Wang L.
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [Abstract] [Full Text] [Related]

  • 26. The role of CD44 adhesion factor in canine mammary carcinomas.
    Madrazo J, García-Fernández RA, García-Iglesias MJ, Durán AJ, Espinosa J, Pérez-Martínez C.
    Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Of humans and canines: Immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours.
    Kumaraguruparan R, Prathiba D, Nagini S.
    Res Vet Sci; 2006 Oct; 81(2):218-24. PubMed ID: 16740286
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. p63: a novel myoepithelial cell marker in canine mammary tissues.
    Gama A, Alves A, Gartner F, Schmitt F.
    Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of FOXP3 expression in canine mammary gland tumours.
    Oh SY, Ryu HH, Yoo DY, Hwang IK, Kweon OK, Kim WH.
    Vet Comp Oncol; 2014 Mar; 12(1):20-8. PubMed ID: 22541038
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
    Ressel L, Millanta F, Caleri E, Innocenti VM, Poli A.
    Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog.
    de Las Mulas JM, Millán Y, Dios R.
    Vet Pathol; 2005 Mar; 42(2):200-12. PubMed ID: 15753474
    [Abstract] [Full Text] [Related]

  • 37. An assessment of the clonality of the components of canine mixed mammary tumours by mitochondrial DNA analysis.
    Bertagnolli AC, Soares P, van Asch B, Amorim A, Cirnes L, Máximo V, Cassali GD.
    Vet J; 2009 Nov; 182(2):269-74. PubMed ID: 18752974
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Expression of Cox-1 and Cox-2 in canine mammary tumours.
    Queiroga FL, Alves A, Pires I, Lopes C.
    J Comp Pathol; 2007 Nov; 136(2-3):177-85. PubMed ID: 17416236
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 35.